SRHQ - ETF AI Analysis
Top Page
SRH U.S. Quality ETF (SRHQ)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, showing solid momentum.
Well-Balanced Sector Mix
Holdings are spread across technology, industrials, health care, consumer, and financial stocks, helping reduce reliance on any single sector.
Top Holdings with Strong Gains
Several of the largest positions, especially in health care and infrastructure, have posted strong performance, supporting the fund’s overall returns.
Negative Factors
Higher-Than-Index Expense Ratio
The fund’s expense ratio is higher than many broad U.S. index ETFs, which slightly reduces the net return investors keep.
Heavy U.S.-Only Focus
Almost all assets are invested in U.S. companies, offering little diversification across global markets.
Sector Concentration in a Few Areas
A large share of the portfolio is concentrated in technology, industrials, and health care, which could hurt performance if these sectors weaken.
SRHQ vs. SPDR S&P 500 ETF (SPY)
AUM222.63M
RegionNorth America
Expense Ratio0.35%
Beta0.83
IssuerSRH
Inception DateOct 05, 2022
Dividend Yield0.66%
Asset ClassEquity
Index TrackedSRH U.S. Quality GARP Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,385
30 Day Avg. Volume959
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
56.38Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering81
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SRHQ Summary
SRH U.S. Quality ETF (SRHQ) is a fund that invests in high‑quality large U.S. companies, following the SRH U.S. Quality GARP Index. It focuses on firms with strong finances and steady earnings across many sectors, including technology, health care, and industrials. Well-known holdings include UnitedHealth and Humana. An investor might choose this ETF for broad diversification in solid, established businesses with potential for long-term growth. However, because it is fully invested in U.S. stocks, its value can rise and fall with the overall stock market.
How much will it cost me?The SRH U.S. Quality ETF (SRHQ) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than the average for ETFs because it is actively managed, focusing on selecting high-quality large-cap companies rather than simply tracking an index.
What would affect this ETF?The SRH U.S. Quality ETF (SRHQ), with its focus on large-cap U.S. companies in sectors like Technology, Industrials, and Health Care, could benefit from economic growth, technological innovation, and increased demand for healthcare services. However, it may face challenges from rising interest rates, which can impact large-cap companies' borrowing costs, or sector-specific risks such as regulatory changes in technology and healthcare. Its emphasis on quality companies provides resilience, but broader market volatility could still affect performance.
SRHQ Top 10 Holdings
SRHQ leans heavily into U.S. tech and health care, with names like Qualys and Nutanix helping drive returns as their shares keep rising on solid growth stories, even if momentum has been a bit choppy. Humana and Centene add steady health care ballast, quietly supporting performance rather than stealing the spotlight. On the other side, CommVault has been more of a speed bump lately, with weaker near-term trading tempering its longer-term potential. Overall, this is a U.S.-only, quality-focused fund, tilted toward resilient, growth-minded large caps.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Humana | 2.44% | $5.41M | $48.22B | 30.40% | 69 Neutral | |
| Centene | 2.16% | $4.79M | $33.12B | 131.33% | 58 Neutral | |
| Qualys | 2.06% | $4.56M | $5.94B | 27.20% | 78 Outperform | |
| Insperity | 2.03% | $4.49M | $1.98B | -3.78% | 54 Neutral | |
| Nutanix | 1.89% | $4.18M | $18.40B | -2.66% | 62 Neutral | |
| CommVault Systems | 1.85% | $4.09M | $5.65B | -23.78% | 65 Neutral | |
| Abercrombie Fitch | 1.73% | $3.83M | $6.65B | 56.94% | 78 Outperform | |
| Gen Digital | 1.72% | $3.80M | $18.35B | 3.90% | 67 Neutral | |
| frontdoor | 1.65% | $3.65M | $5.69B | 31.01% | 72 Outperform | |
| Dropbox | 1.62% | $3.58M | $7.57B | 16.60% | 62 Neutral |
SRHQ Technical Analysis
Positive
―
Price Trends
48.30
Positive
46.06
Positive
43.18
Positive
Market Momentum
0.40
Positive
55.84
Neutral
53.90
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SRHQ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 49.82, equal to the 50-day MA of 48.30, and equal to the 200-day MA of 43.18, indicating a neutral trend. The MACD of 0.40 indicates Positive momentum. The RSI at 55.84 is Neutral, neither overbought nor oversold. The STOCH value of 53.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SRHQ.
SRHQ Peer Comparison
Comparison Results
Performance Comparison
SRHQ
SRH U.S. Quality ETF
49.72
11.36
29.61%
IUS
Invesco RAFI Strategic US ETF
―
―
―
CVLC
Calvert US Large-Cap Core Responsible Index ETF
―
―
―
FTQI
First Trust Hedged BuyWrite Income ETF
―
―
―
SPHB
Invesco S&P 500 High Beta ETF
―
―
―
INFO
Harbor PanAgora Dynamic Large Cap Core ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents